MIR8055

Across TCGA pan-cancer cohorts, MIR8055 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR8055 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher MIR8055 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR8055 expression acts as an unfavorable survival marker, although some lineages such as BRCA and CESC show a favorable association.

TGCT, KIRC, and SKCM are the cancer types where MIR8055 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	II,III,IV	0.638	0.996	.005	38	view →
KIRC	DFS	Tertile	IV	0.172	0.439	.021	33	view →
SKCM	DFS	Tertile	All	0.624	0.827	<.001	29	view →
THCA	OS	Quartile	IV	0.480	0.932	.003	26	view →
HNSC	OS	Quartile	IV	0.315	0.614	.005	22	view →
BRCA	OS	Median	IV	0.804	0.373	.014	18	view →
CESC	DFS	Tertile	IV	0.879	0.400	.033	18	view →
LIHC	DFS	Tertile	All	0.427	0.576	.017	18	view →
ACC	DFS	Tertile	III,IV	0.046	0.670	.001	18	view →
DLBC	DFS	Tertile	All	0.555	0.949	.020	10	view →
UCEC	DFS	Median	All	0.782	0.867	.008	10	view →
UVM	OS	Tertile	III,IV	0.429	0.762	.028	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR8055–TGCT (DFS)

Open the TGCT breakdown →